Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trialDavid E. Kandzari, Denise Reedus, Garrett Pilcher et al.|The Lancet|2018Cited by 775
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trialRaymond R. Townsend, Felix Mahfoud, David E. Kandzari et al.|The Lancet|2017Cited by 734
Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II studyJavier Escaned, Adrian Banning, Carlos Collet et al.|European Heart Journal|2017Cited by 295
Coronary pressure and flow relationships in humans: phasic analysis of normal and pathological vessels and the implications for stenosis assessment: a report from the Iberian–Dutch–English (IDEAL) collaboratorsSukhjinder Nijjer, Niels van Royen, Guus A. de Waard et al.|European Heart Journal|2015Cited by 169
Fractional Flow Reserve/Instantaneous Wave-Free Ratio Discordance in Angiographically Intermediate Coronary StenosesChristopher Cook, Justin E. Davies, Allen Jeremias et al.|JACC: Cardiovascular Interventions|2017Cited by 129